Researchers developed an explainable AI model to improve breast cancer detection in MRI with lower false positive rates.
Key Details
- 1AI model was trained on over 10,000 contrast-enhanced breast MRI exams from 2005 to 2022.
- 2The dataset included diverse cases and varying categories of breast density for robust training.
- 3Unlike prior models, this AI was evaluated on both low- and high-prevalence cancer cohorts, improving clinical relevance.
- 4The model features explainability to provide evidence-backed decisions, critical for clinical adoption.
- 5A key aim is to reduce false positive rates, a common issue in breast MRI diagnostics.
Why It Matters
False positives in breast MRI can lead to unnecessary anxiety and follow-up tests. Explainable, robust AI models like this can aid radiologists in accurate cancer detection and support clinical integration through transparency.
Source
Health Imaging
Related News
•Radiology Business
Lucida Medical Raises $11M for AI-Based Prostate MRI Diagnosis Expansion
Lucida Medical, specializing in AI-assisted prostate cancer diagnosis via MRI, raises $11.4M to drive US FDA approval and platform expansion.
•Radiology Business
UCLA Appoints Inaugural Associate Dean for Health AI Strategy
UCLA has appointed Katherine P. Andriole as its first associate dean for Health AI Strategy and Innovation, with an initial focus on radiology.
•AuntMinnie
AI Models Reveal Racial Disparities in Breast Cancer Patterns
Machine learning models reveal significant racial disparities and key predictors in breast cancer incidence across diverse groups.